Cancer Genetics to Host Fourth Quarter and Full Year 2017 Financial Results
March 26, 2018 07:30 ET
|
Cancer Genetics, Inc.
RUTHERFORD, N.J., March 26, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX), a leader in enabling precision medicine for oncology through molecular markers and diagnostics, today...
Cancer Genetics, Inc. Chief Executive Officer Steps Down
February 05, 2018 08:12 ET
|
Cancer Genetics, Inc.
• Board Appoints COO, Jay Roberts, Interim Chief Executive Officer RUTHERFORD, N.J., Feb. 05, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX) an emerging leader in enabling precision...
Cancer Genetics Expands Its Industry-Leading Immuno-Oncology Panel, Complete::IO™, to be the Most Comprehensive for Immune Profiling & Monitoring
January 17, 2018 07:30 ET
|
Cancer Genetics, Inc.
- Simultaneously Assesses 27 Unique Immune Markers - Determines Optimal IO Therapies and Tracks Response and Resistance Mechanisms RUTHERFORD, N.J., Jan. 17, 2018 (GLOBE NEWSWIRE) -- Cancer...
Cancer Genetics Receives Non-Dilutive Funding of $1.1 Million through New Jersey Technology Business Tax Certificate Transfer (NOL) Program
December 28, 2017 07:00 ET
|
Cancer Genetics, Inc.
RUTHERFORD, N.J., Dec. 28, 2017 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX), a leader in enabling precision medicine for oncology through molecular markers and diagnostics, today...
Cancer Genetics Receives New York State Approval for FDA-Approved Oncomine Dx Target Test by Thermo Fisher Scientific
December 19, 2017 07:30 ET
|
Cancer Genetics, Inc.
The test serves as a companion diagnostic for three targeted therapies in non-small cell lung cancer (NSCLC) Global NSCLC diagnostic market projected to reach $3.65 billion by 2024 RUTHERFORD,...
Cancer Genetics advances understanding of immune response and measurement in lymphomas by combining PD-L1 expression analysis with RNA analysis
December 11, 2017 07:30 ET
|
Cancer Genetics, Inc.
Study Presented at the 59th American Society of Hematology (ASH) Annual MeetingStudy focused on DLBCL (Diffuse Large B-Cell Lymphomas) RUTHERFORD, N.J., Dec. 11, 2017 (GLOBE NEWSWIRE) -- Cancer...
Cancer Genetics Prices $7 Million Registered Direct Offering
December 08, 2017 08:58 ET
|
Cancer Genetics, Inc.
RUTHERFORD, N.J., Dec. 08, 2017 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX), a leader in enabling precision medicine for oncology through molecular markers and diagnostics, today...
Cancer Genetics to Participate in Upcoming Investor Conferences
November 30, 2017 08:00 ET
|
Cancer Genetics, Inc.
RUTHERFORD, N.J., Nov. 30, 2017 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX), a leader in enabling precision medicine for oncology through molecular markers and diagnostics, today...
Cancer Genetics Initiates Partnership to Reduce Alarmingly Increasing Cancer Mortality Rates in India
November 29, 2017 08:02 ET
|
Cancer Genetics, Inc.
Collaboration with India’s premier professional oncology organization, the Indian Cooperative Oncology Network (ICON)Goal to bring CGI’s global expertise in clinical diagnostic assay development and...
Cancer Genetics and Indian Cooperative Oncology Network (ICON) Collaborate to Reduce Alarmingly Increasing Cancer Mortality Rates
November 29, 2017 08:00 ET
|
Cancer Genetics, Inc.
Goal to bring CGI’s global expertise in clinical diagnostic assay development and as a drug development partner to optimize clinical outcomes for cancer patients; Aim to develop educational and...